EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mechanistic insights into the small-molecule inhibition of influenza A virus entry

Yan Xu, Varada Anirudhan iD, Irina N Gaisina iD, Haijuan Du, Saad Alqarni iD, Terry W Moore iD, Michael Caffrey, Balaji Manicassamy iD, Tongqing Zhou, Lijun Rong iD, Kai Xu iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2503899122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Yan Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210. Hauptthemen laut MEDLINE: Virus Internalization, Antiviral Agents, Influenza A virus, Hemagglutinin Glycoproteins, Influenza Virus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, OSU | Center for Clinical and Translational Science, Ohio State University (CCTS, OSU), HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza A virus (IAV) is a zoonotic pathogen responsible for seasonal and pandemic flu. The extensive genetic and antigenic diversity within and between IAV phylogenetic groups presents major challenges for developing universal vaccines and broad-spectrum antiviral therapies. Current interventions provide limited protection due to the virus’s high mutation rate and capacity for immune evasion. Recent advancements in viral hemagglutinin (HA)-targeting small-molecule entry inhibitors offer a promising avenue to overcome these limitations. Here, we present structural and functional analyses of two group 2 HA-specific small-molecule inhibitors recently identified by our team. Cryogenic electron microscopy (cryo-EM) structures revealed that these inhibitors bind a conserved pocket within the HA stalk, likely interfering with the conformational rearrangements necessary for membrane fusion and viral entry. Structure-guided mutagenesis confirmed the critical roles of key interacting residues and uncovered distinct resistance profiles between the two compounds, as well as in comparison to Arbidol, a previously reported HA inhibitor. Notably, our structural analysis highlights intrinsic barriers to achieving cross-group inhibition with current small-molecule designs. To address this, we propose an alternative strategy for broadening antiviral coverage. Together, these findings provide mechanistic insights into IAV entry inhibition and a foundation for the rational design of next-generation anti-influenza therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus InternalizationAntiviral AgentsInfluenza A virusHemagglutinin Glycoproteins, Influenza VirusSmall Molecule LibrariesHumansCryoelectron MicroscopyAnimalsMadin Darby Canine Kidney CellsDogsInfluenza, Human

Stichwörter der Autor:innen

Influenza A virusantiviralcryo-electron microscopyhemagglutininsmall molecule inhibitors

Substanzen

Antiviral AgentsHemagglutinin Glycoproteins, Influenza VirusSmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.
  • Department of Microbiology and Immunology, University of Illinois, Chicago, IL 60612.
  • Department of Pharmaceutical Sciences and UICentre, Retzky College of Pharmacy, University of Illinois, Chicago, IL 60612.
  • Chicago BioSolutions Inc., Chicago, IL 60612.
  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, University of Ha'il, Hail 55473, Saudi Arabia.

ORCID-Profile: Varada Anirudhan, Irina N Gaisina, Saad Alqarni, Terry W Moore, Balaji Manicassamy, Lijun Rong, Kai Xu

Förderung

  • NIAID NIH HHS
  • OSU | Center for Clinical and Translational Science, Ohio State University (CCTS, OSU)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)

Zitieren

APA

Xu, Y., Anirudhan, V., Gaisina, I. N., Du, H., Alqarni, S., Moore, T. W., Caffrey, M., Manicassamy, B., Zhou, T., Rong, L., & Xu, K. (2025). Mechanistic insights into the small-molecule inhibition of influenza A virus entry. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2503899122

Vancouver

Xu Y, Anirudhan V, Gaisina IN, Du H, Alqarni S, Moore TW, et al. Mechanistic insights into the small-molecule inhibition of influenza A virus entry. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2503899122

BibTeX
@article{Xu2025,
  author = {Xu, Yan and Anirudhan, Varada and Gaisina, Irina N and Du, Haijuan and Alqarni, Saad and Moore, Terry W and Caffrey, Michael and Manicassamy, Balaji and Zhou, Tongqing and Rong, Lijun and Xu, Kai},
  title = {Mechanistic insights into the small-molecule inhibition of influenza A virus entry},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2503899122}
}
Kostenlos starten →